Dashboard
Analysis
Charting
Screener
Resources
Settings
NasdaqGS-MEDP
Mar '15
Dec '16
Sep '18
Jun '20
Mar '22
Dec '23
Sep '25
Trailing Valuation
Stock Price
514.2
313.9
304.7
332.2
333.8
411.9
Total Shares Outstanding
28.2
28.1
29.8
30.6
31.1
31
Market Cap
14,483
8,815.9
9,090.8
10,176.5
10,375
12,768
Total Enterprise Value (TEV)
14,316.7
8,894.5
8,776
9,633.3
9,846.4
12,388.9
Buyback Yield
7.3%
12.9%
-0.4%
1.5%
-0.2%
-0.1%
Debt Paydown Yield
—
Shareholder Yield
P/S
6.1
4
4.2
4.8
5
6.3
P/Gross Profit
19.7
12.5
13.4
15.5
16.9
22.1
P/E
36
23.3
26.3
29.2
38.7
Earnings Yield
2.8%
4.3%
3.8%
3.4%
2.6%
P/OCF
20.4
14.4
15.6
16.7
18.1
23.7
P/FCF
21.4
15.2
16.8
17.8
19.4
25.4
FCF Yield
4.7%
6.6%
6%
5.6%
5.2%
3.9%
P/B
49.3
51.2
15.3
12.3
11.8
EV/Sales
4.1
4.6
EV/Gross Profit
19.5
12.6
12.9
14.7
16
EV/EBITDA
26.7
17.6
20.2
22.5
30.3
EV/EBIT
18.6
19.2
21.6
24.1
32.5
EV/OCF
20.1
14.5
15.1
15.8
17.1
22.9
EV/FCF
21.2
16.2
18.4
24.6
Margins
Gross Profit Margin
29.8%
31.9%
33.2%
31.7%
29.1%
Operating Margin
21.5%
20.9%
20.3%
23.4%
21.1%
19.9%
EBITDA Margin
22.6%
22.1%
21.6%
24.8%
22.5%
21.3%
Net Profit Margin
16.8%
15%
20.5%
21.8%
18.1%
16.7%
Effective Tax Rate
22.2%
27.5%
3%
12.6%
18.8%
20%
Pre-Tax Profit Margin
20.6%
21.2%
25%
22.3%
Free Cash Flow Margin
35.7%
23.6%
20.7%
34.1%
26%
19.6%
OCF / Sales
37.3%
24.6%
35.5%
28%
22%
OCF / Net Income
221.5%
164.6%
109.8%
162.9%
154.6%
131.7%
FCF / OCF
95.6%
95.9%
92.1%
96%
92.9%
88.9%
FCF / Net Income
211.9%
157.8%
101.1%
156.4%
143.7%
117.2%
FCF / EBITDA
158.2%
106.8%
96.2%
137.7%
115.6%
Capital Efficiency
Return on Invested Capital
5.1%
6.2%
6.3%
5.4%
5%
Return on Assets
5.8%
Return on Equity
18.9%
19.3%
16.9%
14.3%
15.3%
Return on Total Capital
89%
71.2%
83.6%
81.5%
67%
51.5%
Return on Capital Employed
19.8%
14.1%
14.5%
13.4%
14.2%
Return on Tangible Assets
9.1%
8.6%
10%
9.9%
8.9%
9.2%
Receivables Turnover
1.9
1.8
Days Sales Outstanding
189.3
205.4
188.6
202.3
206.8
199.1
Payables Turnover
12
8.9
11.1
13.2
Days Payables Outstanding
20.8
30.5
41.1
32.8
27.7
29.7
Cash Conversion Cycle
168.5
174.9
147.5
169.5
179.1
169.4
Asset Turnover
0.3
Fixed Asset Turnover
2.6
2.3
2.2
2.1
Operating Cycle
CapEx to OCF
0
0.1
CapEx to Revenue
CapEx to Depreciation
1.5
0.9
1.4
1
Financial Health
Total Debt
119.1
124.9
126.7
126.2
128.3
131.8
Net Debt
-166.3
78.6
-314.8
-543.2
-528.6
-379.1
Current Ratio
0.6
0.4
0.7
Quick Ratio
0.5
0.8
Cash Ratio
0.2
Debt Ratio
Assets to Equity
6
9.1
3.2
2.5
2.4
Cash Flow to Debt Ratio
1.2
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
-722.1
-878.5
-482.3
-246.1
-170
-283.9
Goodwill / Assets
Debt / Equity
Total Debt / Capitalization
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
-1.1
-2.6
-4.1
-4.4
-3.4
EBIT / Interest Expense
-15.9
EBITDA / Interest Expense
-16.9
(EBITDA - Capex) / Interest Expense
Per Share
Revenue per Share
20.7
17.9
16.6
16.5
Basic EPS
3.8
3.1
2.9
Diluted EPS
3.9
3.7
3
2.8
Book Value per Share
10.2
5.9
19
25.9
27.5
23.8
Tangible Book Value per Share
-14
-18
-3.3
5.7
Cash per Share
9.9
1.6
14.2
21
20.5
15.9
Operating Cash Flow per Share
8.5
5.1
3.6
Free Cash Flow per Share
8.2
4.9
4.3
CapEx per Share
Weighted Avg. Shares Outstanding
28.6
30.4
30.9
Weighted Avg. Shares Outstanding Diluted
28.8
29.1
31.2
31.9
32.1
Common Size
SG&A to Revenue
7.7%
10.4%
8.5%
7.8%
Stock-based Comp to Revenue
1%
1.1%
2.2%
0.7%
